Hydrazinobenzoylcurcumin inhibits androgen receptor activity and growth of castration-resistant prostate cancer in mice
Authors:
Open Access
- 31 January 2015
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (8) , 6136-6150
Abstract
There is a critical need for therapeutic agents that can target the amino-terminal domain (NTD) of androgen receptor (AR) for the treatment of castration-resistant prostate cancer (CRPC). Calmodulin (CaM) binds to the AR NTD and regulates AR activity. We discovered that Hydrazinobenzoylcurcumin (HBC), which binds exclusively to CaM, inhibited AR activity. HBC abrogated AR interaction with CaM, suppressed phosphorylation of AR Serine81, and blocked the binding of AR to androgen-response elements. RNA-Seq analysis identified 57 androgen-regulated genes whose expression was significantly (p ≤ 0.002) altered in HBC treated cells as compared to controls. Oncomine analysis revealed that genes repressed by HBC are those that are usually overexpressed in prostate cancer (PCa) and genes stimulated by HBC are those that are often down-regulated in PCa, suggesting a reversing effect of HBC on androgen-regulated gene expression associated with PCa. Ingenuity Pathway Analysis revealed a role of HBC affected genes in cellular functions associated with proliferation and survival. HBC was readily absorbed into the systemic circulation and inhibited the growth of xenografted CRPC tumors in nude mice. These observations demonstrate that HBC inhibits AR activity by targeting the AR NTD and suggest potential usefulness of HBC for effective treatment of CRPC.Keywords
This publication has 51 references indexed in Scilit:
- AR function in promoting metastatic prostate cancerCancer and Metastasis Reviews, 2014
- Small Molecule Inhibitors Targeting the “Achilles' Heel” of Androgen Receptor ActivityCancer Research, 2011
- CDK9 Regulates AR Promoter Selectivity and Cell Growth through Serine 81 PhosphorylationMolecular Endocrinology, 2010
- Phosphorylation and Activation of Androgen Receptor by Aurora-AJournal of Biological Chemistry, 2010
- Rapid calcium-dependent activation of Aurora-A kinaseNature Communications, 2010
- A Novel Ca2+/Calmodulin Antagonist HBC Inhibits Angiogenesis and Down-regulates Hypoxia-inducible FactorJournal of Biological Chemistry, 2010
- Nitric Oxide-Mediated Histone Hyperacetylation in Oral Cancer: Target for a Water-Soluble HAT Inhibitor, CTK7AChemistry & Biology, 2010
- Androgen Receptor Structural and Functional Elements: Role and Regulation in Prostate CancerMolecular Endocrinology, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- An increase in calmodulin during growth of normal and cancerous liver in vivoFEBS Letters, 1981